COVID-19: Kazakhstan Launches Vaccination with National Vaccine

Nur-Sultan | On Monday, Kazakhstan launched a coronavirus vaccination campaign with an injection developed by the Central Asian country called QazVac, which is currently in phase III clinical trials.

According to state television, 50,000 doses of a two-dose vaccine developed by the State Institute for Biosafety Research have been distributed throughout Kazakhstan.

Health Minister Aleksey Tsoi received the first dose of the vaccine live on television, said he felt “good” and added that the government is in talks with Turkey to produce additional batches.

The President of Kazakhstan, Kassym-Jomart Tokayev, for his part, welcomed the scientific breakthrough of his country, which has become “one of the few countries” in the world that has developed its own vaccine against COVID-19.

Kazakhstan was the first foreign country to produce the Russian Sputnik V vaccine on its territory, which has so far dominated its coronavirus immunization campaign.

According to Tsoi, every 20 people in Kazakhstan have been vaccinated since the start of the campaign in February.

More than 309,000 people have been infected with COVID-19 and 3,570 have died in the country of 19 million, according to official figures on Monday.

A former Soviet republic, Kazakhstan is the main economy of Central Asia with abundant hydrocarbon and natural resources.

Back to top button